期刊文献+

卡维地罗对急性心梗患者心电QT离散度及室性心律失常的影响

卡维地罗对急性心梗患者心电QT离散度及室性心律失常的影响
下载PDF
导出
摘要 目的卡维地罗对急性心肌梗死QT离散度(Qrd)及室性心律失常的影响。方法将急性心肌梗死患者随机分为:卡维地罗组(n=34)和倍他乐克组(n=33)。两组服药4周以上。分别测定入院当天、2周后及4周后QTd和24h动态心电图监测室性心律失常情况。结果经卡维地罗治疗2周、4周后Qtd和室性心律失常较入院时明显改善;与倍他乐克治疗效果相当。结论卡维地罗能有效的控制急性心肌梗死QT离散度及室性心律失常。 Objective Carvedilor opposes acute cardiac arrest QT relative dispersion (QTd) and the room arrythmia the influence. Methods Divides into stochastically the acute cardiac arrest patient: Carvedilor group (n=34) and Metoprolol group (n=33). Two groups take medicine above for 4 weeks. Distinction determination in hospital at the same day, 2 weeks later and 4 weeks later QTd and 24 h dynamic electrocardiogram monitor room arrythmia situation. Results Treats 2 week, 4 weeks later QTd and the room arrythmia is hospitalized when the distinct improvement Carvedilor; With Metoprolol treatment result quite. Conclusion Carvedilor can the effective control acute cardiac arrest QT relative dispersion and the room arrythmia. Carvedilor can the effective control acute cardiac arrest QT relative dispersion and the room arrythmia.
作者 潘英
出处 《当代医学》 2008年第8期13-14,共2页 Contemporary Medicine
关键词 Β受体阻滞剂 心肌梗死 心脏事件 β Acceptor retarder Cardiac arrest Heart event
  • 相关文献

参考文献1

二级参考文献19

  • 1Brouet A, Sonveaux P, Dessy C, et al. Hsp90 and caveolin are key targets for the proangiogenic nitic oxide-mediated effects of statins. Circ Res, 2001,89:866-873.
  • 2Su SF, Hsaio CL, Chu CW, et al. Effects of pravastatin on left ventricular mass in patients with hyperlipidemia and essential hypertension. Am J Cardiol, 2000, 86:514-518.
  • 3Lee TM, Chou TF, Tsai CH. Association of pravastatin and left ventricular mass in hyper- cholesterolemia patients: role of 8-Iso-Prostaglandin F2α formation. J Cardiovasc Pharmacol, 2002, 40:868-874.
  • 4Luo JD, Zhang WW, Zhang GP, et al. Effects of simvastatin on left ventricular hypertrophy and function in rats with aortic stenosis. Acta Pharmacol Sin, 1999, 20: 345-348.
  • 5Aikawa R, Komuro I, Yamazaki T, et al. Oxidative stress activates extracellular signal-regulated kinase through Src and Ras in culured cardiac myocytes of neonatal rats. J Clin Invest, 1997, 100:1813-1821.
  • 6Bauersachs J, Galuppo P, Fraccarollo D, et al. Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction. Circulation, 2001,104
  • 7Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet, 1994, 344:1383-1389.
  • 8Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med, 1995, 333:1301-1307.
  • 9Bonetti PO, Lerman LO, Napoli C, et al. Statin effects beyond lipid lowering-are they clinically relevant? Eur Heart J, 2003, 24:225-248.
  • 10Indolfi C, Di Lorenzo E, Perrino C, et al. Hydroxy-methylglutaryl-conezyme A reductase inhibitior simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation. Circulation, 2002, 106:2118-2124.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部